Netupitant; Palonosetron Hydrochloride Global Patent Coverage & Expiry Overview

Track protection status across key markets to assess launch feasibility.

Start your free 7-Day Trial! Book a demo to explore our global patent data.

It is formulated by 1 pharmaceutical company such as HELSINN HLTHCARE. It is marketed under 1 brand name, including AKYNZEO. Available in 1 different strength, such as 300MG;EQ 0.5MG BASE, and administered through 1 route including CAPSULE;ORAL.

Strategic Dashboard

info

insightsStrategic Insights

Sourcing & Feasibility

check_circle API availability: autorenew Loading API feasibility...

groups Licensing: 1 potential partners

calendar_todayUS Launch window: autorenew Loading launch window...

timeline Key Patent Barrier & Expiry Timeline

autorenew Loading patent barriers...

factoryGeneric Manufacturer Snapshot

autorenew Loading manufacturers...

gavelRisk & Opportunity Summary

dangerous Risk: autorenew Loading risk analysis...
watch_later Watch: autorenew Loading watch analysis...
rocket_launch Opportunity: autorenew Loading opportunity analysis...
flag
gavel
calendar_today
calendar_today

Access Global Patent Data

Stay ahead with worldwide patent expiry and latest updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
Unlock Global Patents

Orange Book Drug Approval Timeline

FDA approval history for this ingredient

NDA (New Drug Application) ANDA (Generic Application)

Access Global Exclusivity and Patent Expiry Extensions

Stay ahead with worldwide patent expiry insights, exclusivity data, and latest updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
✓ Latest exclusivity data and extensions
Unlock Global Access

US Orange Book Patents Expiration Timeline

Key expiration dates for US patents covering this ingredient

View Global Patents Expiration Timeline

Stay ahead with worldwide patent expiry insights, market data, and research updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
Unlock Global Patent Timeline

Orange Book Drug Strengths

Latest drug strengths approved by FDA

Strength Route of Administration Companies Latest Approval Date

Orange Book Patents

Patents approved by the FDA for the ingredient

Patent Number Publication Date Legal Status Patent Expiry Date
{"application_id":"45556","ingredient":"NETUPITANT; PALONOSETRON HYDROCHLORIDE","trade_name":"AKYNZEO","family_id":"0aa6b3f3bcd9410fabee","publication_number":"US8951969B2","cleaned_patent_number":"8951969","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-11-18","publication_date":"2015-02-10","legal_status":"Granted"} US8951969B2 Formulation 10 Feb, 2015 Granted 18 Nov, 2030
{"application_id":"45555","ingredient":"NETUPITANT; PALONOSETRON HYDROCHLORIDE","trade_name":"AKYNZEO","family_id":"0aa6b3f3bcd9410fabee","publication_number":"US8623826B2","cleaned_patent_number":"8623826","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-11-18","publication_date":"2014-01-07","legal_status":"Granted"} US8623826B2 07 Jan, 2014 Granted 18 Nov, 2030
{"application_id":"45557","ingredient":"NETUPITANT; PALONOSETRON HYDROCHLORIDE","trade_name":"AKYNZEO","family_id":"0aa6b3f3bcd9410fabee","publication_number":"US9186357B2","cleaned_patent_number":"9186357","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-11-18","publication_date":"2015-11-17","legal_status":"Granted"} US9186357B2 17 Nov, 2015 Granted 18 Nov, 2030
{"application_id":"45493","ingredient":"NETUPITANT; PALONOSETRON HYDROCHLORIDE","trade_name":"AKYNZEO","family_id":"0aa6b3f3bcd9410fabee","publication_number":"US9943515B2","cleaned_patent_number":"9943515","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-11-18","publication_date":"2018-04-17","legal_status":"Granted"} US9943515B2 17 Apr, 2018 Granted 18 Nov, 2030
{"application_id":"45560","ingredient":"NETUPITANT; PALONOSETRON HYDROCHLORIDE","trade_name":"AKYNZEO","family_id":"e5c41947226848f6bfc5","publication_number":"US11559523B2","cleaned_patent_number":"11559523","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-11-18","publication_date":"2023-01-24","legal_status":"Granted"} US11559523B2 Formulation 24 Jan, 2023 Granted 18 Nov, 2030
{"application_id":"130683","ingredient":"NETUPITANT; PALONOSETRON HYDROCHLORIDE","trade_name":"AKYNZEO","family_id":"","publication_number":"US12042494B2","cleaned_patent_number":"12042494","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-11-18","publication_date":"2024-07-23","legal_status":"Granted"} US12042494B2 Formulation 23 Jul, 2024 Granted 18 Nov, 2030
{"application_id":"45559","ingredient":"NETUPITANT; PALONOSETRON HYDROCHLORIDE","trade_name":"AKYNZEO","family_id":"0aa6b3f3bcd9410fabee","publication_number":"US10828297B2","cleaned_patent_number":"10828297","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-12-17","publication_date":"2020-11-10","legal_status":"Granted"} US10828297B2 10 Nov, 2020 Granted 17 Dec, 2030
{"application_id":"45558","ingredient":"NETUPITANT; PALONOSETRON HYDROCHLORIDE","trade_name":"AKYNZEO","family_id":"0aa6b3f3bcd9410fabee","publication_number":"US9271975B2","cleaned_patent_number":"9271975","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-09-09","publication_date":"2016-03-01","legal_status":"Granted"} US9271975B2 01 Mar, 2016 Granted 09 Sep, 2031
{"application_id":"45575","ingredient":"NETUPITANT; PALONOSETRON HYDROCHLORIDE","trade_name":"AKYNZEO","family_id":"bb9ef7f9aec04ced8017","publication_number":"US9951016B2","cleaned_patent_number":"9951016","drug_product_flag":"Y","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-09-25","publication_date":"2018-04-24","legal_status":"Granted"} US9951016B2 Molecular Formulation 24 Apr, 2018 Granted 25 Sep, 2035
{"application_id":"45576","ingredient":"NETUPITANT; PALONOSETRON HYDROCHLORIDE","trade_name":"AKYNZEO","family_id":"bb9ef7f9aec04ced8017","publication_number":"US10676440B2","cleaned_patent_number":"10676440","drug_product_flag":"Y","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-09-25","publication_date":"2020-06-09","legal_status":"Granted"} US10676440B2 Molecular Formulation 09 Jun, 2020 Granted 25 Sep, 2035
{"application_id":"45577","ingredient":"NETUPITANT; PALONOSETRON HYDROCHLORIDE","trade_name":"AKYNZEO","family_id":"bb9ef7f9aec04ced8017","publication_number":"US10961195B2","cleaned_patent_number":"10961195","drug_product_flag":"Y","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-09-25","publication_date":"2021-03-30","legal_status":"Granted"} US10961195B2 Molecular Formulation 30 Mar, 2021 Granted 25 Sep, 2035
{"application_id":"45567","ingredient":"NETUPITANT; PALONOSETRON HYDROCHLORIDE","trade_name":"AKYNZEO","family_id":"bb9ef7f9aec04ced8017","publication_number":"US10233154B2","cleaned_patent_number":"10233154","drug_product_flag":"-","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-09-25","publication_date":"2019-03-19","legal_status":"Granted"} US10233154B2 Molecular 19 Mar, 2019 Granted 25 Sep, 2035

Recent Clinical Trials

Latest clinical trials and research studies for this ingredient

NCT ID Title Status Phase Conditions Start Date Completion Date

API Suppliers/Manufacturer (Branded/Generic companies)

Manufacturing Locations

View Complete Supplier List

Unlock access to all suppliers of Netupitant; Palonosetron Hydrochloride

✓ Access a comprehensive list of global suppliers
✓ Get information on each supplier
Unlock Suppliers

Note: Patent expirations and exclusivity timelines are dynamic and may shift based on litigation, regulatory extensions, and maintenance filings. Regular monitoring is advised.

GreyB © 2025 Elixir. All rights reserved.